164 related articles for article (PubMed ID: 7503312)
21. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
Thissen JP; Verniers J
Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
[TBL] [Abstract][Full Text] [Related]
23. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.
Priego T; Ibáñez de Cáceres I; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E50-6. PubMed ID: 13129855
[TBL] [Abstract][Full Text] [Related]
24. Acute effects of growth hormone in alcohol-fed rats.
Lang CH; Liu X; Nystrom G; Wu D; Cooney RN; Frost RA
Alcohol Alcohol; 2000; 35(2):148-58. PubMed ID: 10787390
[TBL] [Abstract][Full Text] [Related]
25. Alteration of somatotropic function by proinflammatory cytokines.
Frost RA; Lang CH
J Anim Sci; 2004; 82 E-Suppl():E100-109. PubMed ID: 15471789
[TBL] [Abstract][Full Text] [Related]
26. The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.
Wang P; Li N; Li JS; Li WQ
World J Gastroenterol; 2002 Jun; 8(3):531-6. PubMed ID: 12046086
[TBL] [Abstract][Full Text] [Related]
27. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
Granado M; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
[TBL] [Abstract][Full Text] [Related]
28. IGF-I/IGFBPs system response to endotoxin challenge in sheep.
Briard N; Dadoun F; Pommier G; Sauze N; Lebouc Y; Oliver C; Dutour A
J Endocrinol; 2000 Mar; 164(3):361-9. PubMed ID: 10694376
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
[TBL] [Abstract][Full Text] [Related]
30. Alcohol-induced increases in insulin-like growth factor binding protein-1 are partially mediated by TNF.
Kumar V; Silvis C; Nystrom G; Deshpande N; Vary TC; Frost RA; Lang CH
Alcohol Clin Exp Res; 2002 Oct; 26(10):1574-83. PubMed ID: 12394292
[TBL] [Abstract][Full Text] [Related]
31. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis.
Lang CH; Fan J; Cooney R; Vary TC
Am J Physiol; 1996 Mar; 270(3 Pt 1):E430-7. PubMed ID: 8638689
[TBL] [Abstract][Full Text] [Related]
32. Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis.
Lang CH; Vary TC; Frost RA
Endocrinology; 2003 Sep; 144(9):3922-33. PubMed ID: 12933666
[TBL] [Abstract][Full Text] [Related]
33. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production.
Renier G; Clément I; Desfaits AC; Lambert A
Endocrinology; 1996 Nov; 137(11):4611-8. PubMed ID: 8895324
[TBL] [Abstract][Full Text] [Related]
34. Determinants of plasma concentrations of insulin-like growth factor-I and albumin and their hepatic mRNAs: the role of dietary protein content and tumor necrosis factor in malnourished rats.
Qu Z; Ling PR; Chow JC; Burke PA; Smith RJ; Bistrian BR
Metabolism; 1996 Oct; 45(10):1273-8. PubMed ID: 8843184
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
[TBL] [Abstract][Full Text] [Related]
36. Role of central IL-1 in regulating peripheral IGF-I during endotoxemia and sepsis.
Lang CH; Fan J; Wojnar MM; Vary TC; Cooney R
Am J Physiol; 1998 Apr; 274(4):R956-62. PubMed ID: 9575956
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-I improves glucose utilization in tumor necrosis factor-treated rats under hyperinsulinemic-euglycemic conditions.
Ling PR; Sierra P; Qu Z; Bistrian BR
Metabolism; 1997 Sep; 46(9):1052-8. PubMed ID: 9284895
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.
Granado M; Priego T; Martín AI; Vara E; López-Calderón A; Angeles Villanúa M
Eur J Pharmacol; 2006 Apr; 536(1-2):204-10. PubMed ID: 16545800
[TBL] [Abstract][Full Text] [Related]
39. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
[TBL] [Abstract][Full Text] [Related]
40. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
Han HJ; Kang CW; Park SH
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
